Towards a Science of Community Engagement in Biomedical HIV Prevention Trials: Towards a Science of Community Engagement in Biomedical HIV Prevention Trials: An Embedded Multiple Case Study in Canada, India, South Africa and Thailand Newman PA, Rubincam CC, Chuang D-M, Lindegger G, Slack C, Chakrapani V, Shunmugam M, Tepjan S, Roungprakhon S, & Canadian HIV Vaccine Initiative Team Background Community stakeholder engagement (SE) is foundational to fair & ethically conducted biomedical HIV prevention trials Scant empirical research has addressed SE To identify cross-cutting & site specific challenges & facilitators of SE in global HIV prevention trials Methods From we conducted an embedded exploratory case study with a multiple case design (n=235)
Multiple Case Study Design CSO representatives Community leaders & advocates Community leaders & advocates Former trial participants Former trial participants Service providers Service providers CasesSubsystemsDecomposition Community members Community members New Conception New Conception of Cases of Cases Synthesis Clinical trialists Ensuring trial literacy Addressing mistrust Processes of meaningful stakeholder engagement Bangkok, Thailand Chennai, India Durban, S. Africa Toronto, Canada
Conclusions Trial literacy: Ensure understanding among community stakeholders of complex trial concepts Historically-based mistrust among local communities Ethical integrity: explore how trials can best meet ethical obligations (e.g. ancillary services, post-trial care) Clear & transparent communication between researchers & trial participants Autonomy & independent decision-making of CABs/CBOs must be balanced with need for training & support